Author: Ravi Shankar

ATHENS, Greece, Oct. 22, 2026 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner of LNG carriers, today announced that its Board of Directors has declared a cash distribution of $0.5625 per unit on its Series A Cumulative Redeemable Perpetual Preferred Units (the “Series A Preferred Units”) (NYSE: DLNG PR A) for the period from August 12, 2026 to November 11, 2026.

The cash distribution is payable on November 12, 2026, to all preferred unit holders of record as of November 4, 2026.

Distributions on the Series A Preferred Units will be payable quarterly in arrears on the 12^th day (unless the 12^th falls on a weekend or public holiday, in which case the payment date is moved to the next business day) of February, May, August and November of each year, when, as and if declared by our Board of Directors. This is the forty-fourth sequential cash distribution on the Series A Preferred Units since they began trading on the NYSE.

The Partnership has 3,000,000 Series A Preferred Units outstanding as of the date of this press release.

About Dynagas LNG Partners LP

Dynagas LNG Partners LP. (NYSE: DLNG) is a master limited partnership which owns and operates liquefied natural gas (LNG) carriers employed on multi-year charters. The Partnership’s current fleet consists of six LNG carriers, with aggregate carrying capacity of approximately 914,000 cubic meters. Visit the Partnership’s website at www.dynagaspartners.com

Contact Information:
Dynagas LNG Partners LP
Attention: Michael Gregos
Tel. +30 210 8917960
Email: management@dynagaspartners.com

Investor Relations/ Financial Media:
Nicolas Bornozis/Markella Kara
Capital Link, Inc.

230 Park Avenue, Suite 1540
New York, NY 10169
Tel. (212) 661-7566
E-mail: dynagas@capitallink.com

Forward-Looking Statements
Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts.

The Partnership desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect,” “expected,” “pending” and similar expressions identify forward-looking statements.

The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, examination by the Partnership’s management of historical operating trends, data contained in its records and other data available from third parties. Although the Partnership believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond the Partnership’s control, the Partnership cannot assure you that it will achieve or accomplish these expectations, beliefs or projections.

In addition to these important factors, other important factors that, in the Partnership’s view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for Liquefied Natural Gas (LNG) shipping capacity, changes in the Partnership’s operating expenses, including bunker prices, drydocking and insurance costs, the market for the Partnership’s vessels, availability of financing and refinancing, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, vessel breakdowns and instances of off-hires and other factors. Please see our filings with the U.S. Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and the Partnership disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication.

GAITHERSBURG, Md., Oct. 22, 2026 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its third quarter 2026 financial results after market close on Thursday, November 5, 2026. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here

Dial-In: Click here

To receive the dial-in number, as well as your personalized PIN, you must register at the above link. Once registered, you will also have the option to have the system dial-out to you once the conference call begins. If you forget your PIN prior to the conference call, you can simply re-register.

Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.

About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Elutia Investor Relations
ir@elutia.com

Renewed agreement continues Adeia’s media IP license with one of the world’s largest television and consumer electronics manufacturers

SAN JOSE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA), the technology company pioneering foundational innovations that shape how the world computes, connects and experiences entertainment, today announced that TCL Electronics Holdings Limited (“TCL”), a global leader in consumer electronics and one of the world’s largest television manufacturers headquartered in Shenzhen, China, has entered into a multi-year license renewal with Adeia for access to its media intellectual property (IP) portfolio.

This renewal underscores the strength of Adeia’s licensing relationships with leading consumer electronics manufacturers globally as they navigate an evolving media technology landscape.

“We’re pleased to continue our relationship with TCL,” said Dr. Mark Kokes, chief revenue officer of Adeia. “This renewal reflects the continued relevance of our media portfolio as smart TVs become increasingly important platforms for streaming, content discovery, personalization, advertising and connected consumer experiences.”

Adeia continues to invest in and expand its media IP portfolio, which has been developed through decades of research and development. This growing portfolio underpins content discovery, personalization, and streaming capabilities for consumer electronics manufacturers worldwide.

About Adeia

Adeia Inc. (Nasdaq: ADEA) develops foundational innovations that shape how the world computes, connects and experiences entertainment. Its inventions span a broad range of semiconductor and media technologies, including 3D interconnect (hybrid bonding) and advanced thermal management for AI datacenters, as well as content discovery, personalization, and streaming. These inventions are licensed to leaders across the chip design and manufacturing, consumer electronics, automotive, digital entertainment, and e-commerce industries. Adeia’s innovations enable more powerful and efficient products, and more immersive, personalized experiences across billions of devices worldwide. Learn more at www.adeia.com.

About TCL

Founded in 1981, TCL—short for “The Creative Life”—is dedicated to empowering smarter, healthier lifestyles through next-generation experiences. Operating through two independent entities, TCL Industries and TCL Technology, TCL delivers innovative solutions spanning TVs, smartphones, audio products, smart home devices, display technologies, and clean energy.

Today, with 50 R&D centers and 47 manufacturing bases globally, TCL operates in over 160 countries and regions, reinforcing its position as a globally competitive smart technology brand. To further inspire greatness, TCL has become an official Worldwide Olympic and Paralympic Partner in the Home Audiovisual Equipment and Home Appliances category. Learn more at https://www.tcl.com/global/en

Contacts

Adeia Investor Relations
Chris Chaney 
IR@adeia.com

Adeia Media Relations
Anna Enerio 
marketing@adeia.com

MONDOVI, Wis., Oct. 22, 2026 (GLOBE NEWSWIRE) — Marten Transport, Ltd. (Nasdaq/GS:MRTN) today reported a 30.7% improvement in net income to $2.9 million, or 4 cents per diluted share, for the third quarter ended September 30, 2026, from $2.2 million, or 3 cents per diluted share, for the third quarter of 2025. For the nine-month period ended September 30, 2026, net income was $9.6 million, or 12 cents per diluted share, compared with $13.7 million, or 17 cents per diluted share, for the 2025 nine-month period.

Operating revenue was $223.2 million for the third quarter of 2026 compared with $220.5 million for the third quarter of 2025. Our intermodal operations, which were sold in 2025, had operating revenue of $9.9 million in the 2025 quarter. Excluding fuel surcharges, operating revenue was $184.2 million for the 2026 quarter compared with $194.0 million for the 2025 quarter. Fuel surcharge revenue increased to $39.0 million for the 2026 quarter from $26.5 million for the 2025 quarter.

Operating revenue was $650.3 million for the first nine months of 2026 compared with $673.5 million for the first nine months of 2025. Our intermodal operations had operating revenue of $33.7 million in the first nine months of 2025. Excluding fuel surcharges, operating revenue was $546.6 million for the 2026 period compared with $593.5 million for the 2025 period. Fuel surcharge revenue increased to $103.7 million for the 2026 period from $80.0 million for the 2025 period.

Operating income improved 11.9% to $3.1 million for the third quarter of 2026 from $2.7 million for the third quarter of 2025.

Operating income was $11.6 million for the first nine months of 2026 compared with $18.3 million for the first nine months of 2025.

Operating expenses as a percentage of operating revenue improved to 98.6% for the 2026 quarter from 98.8% for the 2025 quarter. Operating expenses as a percentage of operating revenue, with both amounts net of fuel surcharges, improved to 98.3% for the 2026 quarter from 98.6% for the 2025 quarter.

Operating expenses as a percentage of operating revenue were 98.2% for the first nine months of 2026 and 97.3% for the first nine months of 2025. Operating expenses as a percentage of operating revenue, with both amounts net of fuel surcharges, were 97.9% for the 2026 period and 96.9% for the 2025 period.

Chairman of the Board and Chief Executive Officer Randolph L. Marten stated, “The truckload freight market has sharply tightened since earlier this year as renewed and enhanced enforcement of federal and state law is removing a meaningful amount of noncompliant and unqualified driver capacity from the marketplace. We are securing higher pricing from our customers for our premium services while enhancing freight quality across our network within these early stages of the freight market upcycle. Our Truckload average rate per total mile, net of fuel surcharges, increased 14.1% over the third quarter of 2025.”

“Despite these positive trends, our earnings were negatively affected by unusually high net fuel and health insurance costs. Relative to our average quarterly levels during the first half of the year, net fuel increased by $3.5 million and health insurance, within salaries, wages and benefits, increased by $2.0 million in the third quarter. Over the same period, the increase in our rate of driver pay negatively impacted results by $1.0 million, while a larger gain on sale of revenue equipment provided a $1.5 million benefit. Collectively, these factors reduced our third quarter net income by $3.7 million, or 4.5 cents per share.”

“We are focused on mitigating the impact of the recent rise in diesel fuel prices to record levels through disciplined fuel expense and fuel surcharge management initiatives. The margin pressure results primarily from the timing lag inherent in truckload industry fuel surcharge programs relative to rapidly rising diesel fuel costs, as well as the higher fuel consumption associated with our temperature-controlled operations.”

“As we continue through our 80^th year, our priorities remain unchanged: delivering safe, premium service, driving operating efficiencies through data and technology, and maintaining rigorous cost discipline. Our strong, debt-free balance sheet provides the financial flexibility to continue investing in our technology and modern fleet, while positioning the Company to capitalize on attractive opportunities for profitable organic growth.”

Current Investor Presentation

Marten Transport, with headquarters in Mondovi, Wis., is a multifaceted business offering a network of time and temperature-sensitive and dry truck-based transportation and distribution capabilities across Marten’s five distinct business platforms – Temperature-Sensitive and Dry Truckload, Dedicated, Brokerage and MRTN de Mexico. Marten’s Intermodal operations were sold effective September 30, 2025. Marten is one of the leading temperature-sensitive truckload carriers in the United States, specializing in transporting and distributing food, beverages and other consumer packaged goods that require a temperature-controlled or insulated environment. The Company offers service in the United States, Mexico and Canada, concentrating on expedited movements for high-volume customers. Marten’s common stock is traded on the Nasdaq Global Select Market under the symbol MRTN.

This press release contains certain statements that may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include a discussion of Marten’s prospects for future growth, including the impact on the freight market of renewed and enhanced enforcement of federal and state law that is removing a meaningful amount of noncompliant and unqualified driver capacity from the marketplace, and by their nature involve substantial risks and uncertainties, and actual results may differ materially from those expressed in such forward-looking statements. Important factors known to the Company that could cause actual results to differ materially from those discussed in the forward-looking statements are discussed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and in Part II, Item 1A of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. The Company undertakes no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACTS: Randy Marten, Chairman of the Board and Chief Executive Officer, Doug Petit, President, and Jim Hinnendael, Executive Vice President and Chief Financial Officer, of Marten Transport, Ltd., 715-926-4216.

MARTEN TRANSPORT, LTD. CONSOLIDATED CONDENSED BALANCE SHEETS
	September 30,				December 31,
(In thousands, except share information)	2026				2025
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	91,503			$	43,278
Escrow deposit		5,000				5,000
Receivables:
Trade, net		96,911				85,807
Other		8,403				13,084
Prepaid expenses and other		22,574				24,532
Total current assets		224,391				171,701
Property and equipment:
Revenue equipment, buildings and land, office equipment and other		1,086,781				1,128,932
Accumulated depreciation		(356,617	)			(352,426	)
Net property and equipment		730,164				776,506
Other noncurrent assets		1,411				1,560
Total assets	$	955,966			$	949,767
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	35,784			$	28,769
Insurance and claims accruals		42,620				43,700
Accrued and other current liabilities		23,038				19,763
Total current liabilities		101,442				92,232
Deferred income taxes		90,278				89,716
Noncurrent operating lease liabilities		82				194
Total liabilities		191,802				182,142
Stockholders’ equity:
Preferred stock, $.01 par value per share; 2,000,000 shares authorized; no shares issued and outstanding		–				–
Common stock, $.01 par value per share; 192,000,000 shares authorized; 81,661,669 shares at September 30, 2026, and 81,542,174 shares at December 31, 2025, issued and outstanding		817				815
Additional paid-in capital		56,364				54,762
Retained earnings		706,983				712,048
Total stockholders’ equity		764,164				767,625
Total liabilities and stockholders’ equity	$	955,966			$	949,767

MARTEN TRANSPORT, LTD. CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)
	Three Months								Nine Months
	Ended September 30,								Ended September 30,
(In thousands, except per share information)	2026				2025				2026				2025
Operating revenue	$	223,231			$	220,470			$	650,300			$	673,544
Operating expenses (income):
Salaries, wages and benefits		72,970				78,972				217,627				236,342
Purchased transportation		37,917				42,284				110,204				123,063
Fuel and fuel taxes		49,302				33,526				128,976				99,234
Supplies and maintenance		15,639				15,585				46,085				46,704
Depreciation		24,458				25,447				74,226				80,224
Operating taxes and licenses		2,252				2,423				6,770				7,291
Insurance and claims		11,153				11,382				33,704				40,611
Communications and utilities		2,118				2,093				6,375				6,536
Gain on disposition of revenue equipment		(3,027	)			(1,903	)			(6,120	)			(8,750	)
Other		7,385				7,923				20,881				23,958
Total operating expenses		220,167				217,732				638,728				655,213
Operating income		3,064				2,738				11,572				18,331
Other		(882	)			(213	)			(2,060	)			(998	)
Income before income taxes		3,946				2,951				13,632				19,329
Income taxes expense		1,037				725				4,002				5,582
Net income	$	2,909			$	2,226			$	9,630			$	13,747
Basic earnings per common share	$	0.04			$	0.03			$	0.12			$	0.17
Diluted earnings per common share	$	0.04			$	0.03			$	0.12			$	0.17
Dividends declared per common share	$	0.06			$	0.06			$	0.18			$	0.18

MARTEN TRANSPORT, LTD. SEGMENT INFORMATION (Unaudited)
									Dollar				Percentage
									Change				Change
	Three Months								Three Months				Three Months
	Ended								Ended				Ended
	September 30,								September 30,				September 30,
(Dollars in thousands)	2026				2025				2026 vs. 2025				2026 vs. 2025
Operating revenue:
Truckload revenue, net of fuel surcharge revenue	$	94,053			$	90,138			$	3,915				4.3	%
Truckload fuel surcharge revenue		23,251				14,691				8,560				58.3
Total Truckload revenue		117,304				104,829				12,475				11.9
Dedicated revenue, net of fuel surcharge revenue		51,442				56,675				(5,233	)			(9.2	)
Dedicated fuel surcharge revenue		15,748				10,335				5,413				52.4
Total Dedicated revenue		67,190				67,010				180				0.3
Brokerage revenue		38,737				38,780				(43	)			(0.1	)
Intermodal revenue, net of fuel surcharge revenue		–				8,369				(8,369	)			(100.0	)
Intermodal fuel surcharge revenue		–				1,482				(1,482	)			(100.0	)
Total Intermodal revenue		–				9,851				(9,851	)			(100.0	)
Total operating revenue	$	223,231			$	220,470			$	2,761				1.3	%
Operating income/(loss):
Truckload	$	(192	)		$	(2,002	)		$	1,810				90.4	%
Dedicated		1,248				3,426				(2,178	)			(63.6	)
Brokerage		2,008				1,607				401				25.0
Intermodal		–				(293	)			293				100.0
Total operating income	$	3,064			$	2,738			$	326				11.9	%
Operating ratio:
Truckload		100.2	%			101.9	%
Dedicated		98.1				94.9
Brokerage		94.8				95.9
Intermodal		–				103.0
Consolidated operating ratio		98.6	%			98.8	%
Operating ratio, net of fuel surcharges:
Truckload		100.2	%			102.2	%
Dedicated		97.6				94.0
Brokerage		94.8				95.9
Intermodal		–				103.5
Consolidated operating ratio, net of fuel surcharges		98.3	%			98.6	%

MARTEN TRANSPORT, LTD. SEGMENT INFORMATION (Unaudited)
									Dollar				Percentage
									Change				Change
	Nine Months								Nine Months				Nine Months
	Ended								Ended				Ended
	September 30,								September 30,				September 30,
(Dollars in thousands)	2026				2025				2026 vs. 2025				2026 vs. 2025
Operating revenue:
Truckload revenue, net of fuel surcharge revenue	$	276,084			$	272,728			$	3,356				1.2	%
Truckload fuel surcharge revenue		62,930				42,978				19,952				46.4
Total Truckload revenue		339,014				315,706				23,308				7.4
Dedicated revenue, net of fuel surcharge revenue		157,194				180,418				(23,224	)			(12.9	)
Dedicated fuel surcharge revenue		40,755				32,091				8,664				27.0
Total Dedicated revenue		197,949				212,509				(14,560	)			(6.9	)
Brokerage revenue		113,337				111,658				1,679				1.5
Intermodal revenue, net of fuel surcharge revenue		–				28,730				(28,730	)			(100.0	)
Intermodal fuel surcharge revenue		–				4,941				(4,941	)			(100.0	)
Total Intermodal revenue		–				33,671				(33,671	)			(100.0	)
Total operating revenue	$	650,300			$	673,544			$	(23,244	)			(3.5	)%
Operating income/(loss):
Truckload	$	1,281			$	42			$	1,239				2,950.0	%
Dedicated		5,310				13,709				(8,399	)			(61.3	)
Brokerage		4,981				6,463				(1,482	)			(22.9	)
Intermodal		–				(1,883	)			1,883				100.0
Total operating income	$	11,572			$	18,331			$	(6,759	)			(36.9	)%
Operating ratio:
Truckload		99.6	%			100.0	%
Dedicated		97.3				93.5
Brokerage		95.6				94.2
Intermodal		–				105.6
Consolidated operating ratio		98.2	%			97.3	%
Operating ratio, net of fuel surcharges:
Truckload		99.5	%			100.0	%
Dedicated		96.6				92.4
Brokerage		95.6				94.2
Intermodal		–				106.6
Consolidated operating ratio, net of fuel surcharges		97.9	%			96.9	%

MARTEN TRANSPORT, LTD. OPERATING STATISTICS (Unaudited)
	Three Months								Nine Months
	Ended September 30,								Ended September 30,
	2026				2025				2026				2025
Truckload Segment:
Revenue (in thousands)	$	117,304			$	104,829			$	339,014			$	315,706
Average revenue, net of fuel surcharges, per tractor per week(1)	$	4,749			$	4,129			$	4,588			$	4,178
Average tractors(1)		1,507				1,661				1,543				1,674
Average miles per trip		506				508				511				523
Non-revenue miles percentage(2)		10.7	%			11.0	%			10.7	%			11.1	%
Total miles (in thousands)		34,825				38,081				108,587				115,575
Dedicated Segment:
Revenue (in thousands)	$	67,190			$	67,010			$	197,949			$	212,509
Average revenue, net of fuel surcharges, per tractor per week(1)	$	3,862			$	3,776			$	3,896			$	3,811
Average tractors(1)		1,013				1,142				1,035				1,214
Average miles per trip		292				292				295				300
Non-revenue miles percentage(2)		1.1	%			1.1	%			1.1	%			1.3	%
Total miles (in thousands)		21,559				23,206				65,960				73,574
Brokerage Segment:
Revenue (in thousands)	$	38,737			$	38,780			$	113,337			$	111,658
Loads		22,141				25,940				70,613				70,450
Intermodal Segment:
Revenue (in thousands)	$	–			$	9,851			$	–			$	33,671
Loads		–				2,956				–				10,168
Average tractors		–				61				–				72
At September 30, 2026 and September 30, 2025:
Total tractors(1)		2,501				2,823
Average age of company tractors (in years)		2.5				2.2
Total trailers		5,065				5,165
Average age of company trailers (in years)		5.3				4.9
Ratio of trailers to tractors(1)		2.0				1.8

	Three Months								Nine Months
	Ended September 30,								Ended September 30,
(In thousands)	2026				2025				2026				2025
Net cash provided by operating activities	$	22,567			$	18,538			$	83,285			$	87,906
Net cash provided by/(used for) investing activities		(30,144	)			5,786				(21,020	)			(35,742	)
Net cash used for financing activities		(4,900	)			(4,891	)			(14,040	)			(14,946	)
Weighted average shares outstanding:
Basic		81,662				81,520				81,623				81,508
Diluted		81,664				81,527				81,625				81,516

(1)	Includes tractors driven by both company-employed drivers and independent contractors. Independent contractors provided 77 and 83 tractors as of September 30, 2026 and 2025, respectively.
(2)	Represents the percentage of miles for which the company is not compensated.

WALTHAM, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 16 newly hired employees. The awards were made as an inducement material to the newly hired employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement equity awards consisted of non-statutory stock options to purchase up to an aggregate of 290,100 shares of Dyne’s common stock at a per share exercise price equal to the closing price of Dyne’s common stock on The Nasdaq Global Select Market on October 20, 2026, and restricted stock units with respect to an aggregate of 92,300 shares of Dyne’s common stock. The stock options have a ten-year term and are scheduled to vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee’s start date and the remainder vesting in 12 equal quarterly installments thereafter, subject to such employee’s continued service to Dyne through the applicable vesting dates. The restricted stock units are scheduled to vest over four years from the applicable employee’s start date in four equal annual installments, subject to such employee’s continued service to Dyne through the applicable vesting dates.

The inducement equity awards are subject to the terms and conditions of award agreements covering the grants and Dyne’s 2024 Inducement Stock Incentive Plan.

About Dyne Therapeutics

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Contacts:
Investors
Mia Tobias
ir@dyne-tx.com
781-317-0353

Media
Stacy Nartker
media@dyne-tx.com 
781-317-1938

ATHENS, Greece, Oct. 22, 2026 (GLOBE NEWSWIRE) — Capital Clean Energy Carriers Corp. (NASDAQ: CCEC) today announced that its board of directors has declared a cash dividend per share of $0.15 for the third quarter of 2026 ended September 30, 2026.

The cash dividend for the third quarter of 2026 will be paid on November 12, 2026, to common shareholders of record on November 3, 2026.

The Company has implemented a Dividend Reinvestment Plan (“DRIP”) whereby common shareholders can elect to have dividends reinvested directly into additional common shares issued by the Company. To participate in the DRIP for the third quarter of 2026, the election deadline is November 3, 2026. For additional information on the plan, including the forms needed to enroll, please visit the website of Computershare Trust Company, N.A., the Company’s transfer agent administering the DRIP, at: www.computershare.com/investor.

The information on www.computershare.com/investor is not incorporated by reference into this press release and should not be considered part of this press release.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any common shares or any other securities, nor will there be any sale of common shares or any other securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Capital Clean Energy Carriers Corp.

Capital Clean Energy Carriers Corp. (NASDAQ: CCEC), an international shipping company, is a leading platform of gas carriage solutions with a focus on energy transition. CCEC’s in-the-water fleet includes 21 high-specification vessels, including 15 latest-generation Liquefied Natural Gas Carriers (“LNG/Cs”), one legacy Neo-Panamax container vessel, two dual-fuel medium gas carriers (“MG/Cs”) and three Handy Liquefied CO2 Multi-Gas Carriers (“HMG/Cs”). In addition, CCEC’s under-construction fleet includes six additional latest-generation LNG/Cs, four MG/Cs, one HMG/C and one LNG dual-fuel bunkering vessel to be delivered between the first quarter of 2027 and the first quarter of 2029.

For more information about CCEC, please visit: www.capitalcleanenergycarriers.com

Forward-Looking Statements
The statements in this press release that are not historical facts may be forward-looking statements (as such term is defined in Section 21E of the Securities Exchange Act of 1934, as amended). These forward-looking statements involve risks and uncertainties that could cause the stated or forecasted results to be materially different from those anticipated. Unless required by law, we expressly disclaim any obligation to update or revise any of these forward-looking statements, whether because of future events, new information, a change in our views or expectations, to conform to actual results or otherwise. We assume no responsibility for the accuracy and completeness of the forward-looking statements. We make no prediction or statement about the performance of our common shares.

Contact Details:

Investor Relations / Media
Brian Gallagher
EVP Investor Relations
Tel. +44-(770) 368 4996
E-mail: b.gallagher@capitalmaritime.com

Nicolas Bornozis / Markella Kara
Capital Link, Inc. (New York)
Tel. +1-212-661-7566
E-mail: ccec@capitallink.com

GARDEN CITY, N.Y., Oct. 22, 2026 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, will release its third quarter 2026 financial results before market open on Thursday, November 5, 2026. The Company will host a conference call to discuss the results on the same day at 11:00 a.m. Eastern Time. The Company will also host an Investor Day on Tuesday, December 1, 2026, at the Nasdaq MarketSite in New York City.

Third Quarter 2026 Conference Call

Investors and analysts may access the live conference call by dialing 1-833-862-0366 (USA) or 1-412-634-6210 (International). In addition, a live webcast of the conference call will be accessible through the investor relations website here.

For those who cannot listen to the live broadcast, an audio replay of the webcast will be available on the Company’s investor relations website at https://lifetimebrands.gcs-web.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International) and entering access code 10212812. 

Investor Day

The Company will host an Investor Day on Tuesday, December 1, 2026, at the Nasdaq MarketSite in New York City, from 11:00 a.m. to 2:00 p.m. Eastern Time. Members of the Company’s senior leadership team will provide an overview of the business, followed by a panel discussion with the Company’s Division Presidents and a question-and-answer session. In-person attendees will also see product displays and demonstrations. Investors and analysts interested in attending in person should RSVP to LCUT@mzgroup.us.

About Lifetime Brands, Inc.

Lifetime Brands is a leading global designer, developer and marketer of a broad range of branded consumer products used in the home. The Company markets its products under well-known kitchenware brands, including Farberware^®, KitchenAid^®, Sabatier^®, Amco Houseworks^®, Chef’n^®, Chicago™ Metallic, Copco^®, Fred^® & Friends, Houdini™, KitchenCraft^®, Kamenstein^®, La Cafetière^®, MasterClass^®, Misto^®, Swing-A-Way^®, Taylor^® Kitchen, Rabbit^®, and Dolly^®; respected tableware and giftware brands, including Mikasa^®, Pfaltzgraff^®, Fitz and Floyd^®, Empire Silver™, Gorham^®, International^® Silver, Towle^® Silversmiths, Wallace^®, Wilton Armetale^®, V&A^®, Royal Botanic Gardens Kew^®, Year & Day^®, Dolly^®, Royal Leerdam^®, and ONIS^®; and valued home solutions brands, including BUILT NY^®, S’well^®, Taylor^® Bath, Taylor^® Kitchen, Taylor^® Weather, Elements^®, Planet Box^®, and Dolly^®. The Company also provides exclusive private label products to leading retailers worldwide.

The Company’s corporate website is www.lifetimebrands.com.

Contacts:

Lifetime Brands, Inc.
Laurence Winoker, Chief Financial Officer
516-203-3590
investor.relations@lifetimebrands.com

or

MZ North America
Shannon Devine
Main: 203-741-8811
LCUT@mzgroup.us

IRVING, Texas, Oct. 22, 2026 (GLOBE NEWSWIRE) — Quest Resource Holding Corporation (Nasdaq: QRHC) (“Quest” or the “Company”), a national leader in environmental waste and recycling services, today announced that it will release results for its third quarter ended September 30, 2026, on Thursday, November 5, 2026, after market close.

Management will host a conference call that same day at 5:00 PM ET to review the Company’s financial results and business outlook. Investors interested in participating in the live call can dial 1-877-270-2148 or 1-412-371-6060 (International). Investors can also access the call online through a listen-only webcast on the investor relations section of Quest’s website at http://investors.qrhc.com/.

The webcast, which may include forward-looking information, will be archived on the Quest investor relations website for at least 90 days and a telephonic playback of the conference call will be available by calling 1-855-669-9658 or 1-412-317-0088 (International). The replay access code is 2229290. The telephonic playback will be available approximately three hours after the conference ends and will be available through November 12, 2026.

About Quest Resource Holding Corporation
Quest is a national provider of waste and recycling services that empower larger businesses to excel in achieving their environmental and sustainability goals and responsibilities. Quest delivers focused expertise across multiple industry sectors to build single-source, customer-specific solutions that generate quantifiable business and sustainability results. Addressing a wide variety of waste streams and recyclables, Quest provides information and data that tracks and reports the environmental results of Quest’s services, gives actionable data to improve business operations, and enables Quest’s customers to excel in their business and sustainability responsibilities. For more information, visit https://questrmg.com/.

Investor Relations Contact
Alpha IR Group
Nick Nelson or Chris Hodges
QRHC@alpha-ir.com
312-445-2870

NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) — Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) announced today that it will release financial results after market close on Wednesday, November 18, 2026, for its fourth quarter and full year 2026. CCIF will host a conference call at 10:00 a.m. EST on Thursday, November 19, 2026, to discuss the results.

The conference call will be available via public webcast via a link on Carlyle Credit Income Fund’s website at www.carlylecreditincomefund.com and will also be available on the website soon after the call’s completion.

About Carlyle Credit Income Fund

Carlyle Credit Income Fund (NYSE: CCIF) is an externally managed closed-end fund focused on investing in primarily equity and junior debt tranches of collateralized loan obligations (“CLOs”). The CLOs are collateralized by a portfolio consisting primarily of U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. CCIF is externally managed by Carlyle Global Credit Investment Management L.L.C. (“CGCIM”), an SEC-registered investment adviser and wholly owned subsidiary of Carlyle. CCIF draws upon the significant scale and resources of Carlyle as one of the world’s largest CLO managers.

Web: www.carlylecreditincomefund.com 

About Carlyle   

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Carlyle AlpInvest. With $485 billion of assets under management as of June 30, 2026, Carlyle’s purpose is to connect people, ideas, and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,500 people in 28 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and on LinkedIn at The Carlyle Group.

Contacts:

Investors:	Media:
Joseph Castilla	Max Berger
+1 (866) 277-8243 investorrelations@carlylecreditincomefund.com	+1 (917) 533-4374 Max.Berger@carlyle.com

Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia

Highlights

• Collaboration aims to accelerate precision oncology research in Australia
• Combines Fortrea’s experience in oncology clinical trials with Omico’s Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program
• Together, Fortrea and Omico offer more efficient investigator site selection and faster patient access by connecting patients with relevant biomarker-driven clinical trials

DURHAM, N.C. and SYDNEY, Oct. 22, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), and Omico, Australia’s leading precision oncology screening and trial matching organization, today announced a collaboration to accelerate precision oncology research by helping connect cancer patients to biomarker-matched clinical trials. By combining Omico’s precision oncology network with Fortrea’s scientific and clinical trial experience, the joint effort aims to improve study planning, site selection and patient recruitment to expand access to biomarker-driven oncology research globally.

Through this initiative, Omico will support Fortrea’s clients in their oncology drug development needs by providing access to patient population insights, including genomic profiling, trial-matching capabilities, real-world oncology data and patient referral pathways in Australia, a key country both for early and late phase Oncology clinical research activities. The collaboration will combine Fortrea’s oncology drug development experience with Omico’s flagship Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program, the largest cancer genomics initiative in Australia. PrOSPeCT is designed to provide molecular profiling and help match patients to biomarker-driven clinical trials and targeted therapies.

“Our collaboration with Omico is about seeking to reach the right patient for the right study as quickly as possible,” said Oren Cohen, M.D., Chief Medical Officer at Fortrea. “Modern oncology development demands ever-greater precision to match specific cancers with the therapies most likely to benefit patients, and to do so as quickly as possible. Our work with Omico accelerates our ability to identify the right patients for biomarker-driven studies in Australia and help advance precision medicine for people with cancer.”

Omico has built one of Australia’s most extensive precision oncology ecosystems, combining molecular profiling, real-world evidence, cohort research programs and a nationwide network of investigators and clinical sites. Omico has reported more than 23,000 consented patients within its clinic-genomic databases and has received referrals from more than 1,600 clinicians across Australia.

“Australia is well positioned to support global biomarker-driven clinical trials, through Omico’s established national precision oncology research infrastructure, expertise and networks,” said Professor David Thomas, Chief Science and Strategy Officer at Omico. “By combining our national data and trial matching capabilities with Fortrea’s global clinical development expertise, we can help international sponsors identify relevant patient populations, plan trials more effectively and support targeted recruitment.”

Fortrea’s oncology expertise is underpinned by thousands of operational professionals and supported by more than 50 oncology physicians on staff. This collaboration comes at a time when modern oncology drug development has accelerated the focus on precision medicine, biomarker-driven development and targeted patient identification. Working together, Fortrea and Omico can offer more efficient site selection and the ability to match patients with appropriate studies tied to their unique genomic data, enabling more people to participate in studies tailored to their specific condition in Australia.

About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn and X and Bluesky.

About Omico
Omico is an independent, national, not-for-profit research organisation changing the way we fight cancer. We work to improve outcomes for Australians with cancer by providing equitable access to precision oncology and translating scientific advances into clinical care and research, and generating the evidence needed to inform health policy and system reform. Working with Australia’s leading cancer institutes, researchers, clinicians, industry partners, advocacy groups and government, we are accelerating molecular profiling, biomarker-led clinical trials, personalised cancer risk management and real-world evidence.

About PrOSPeCT
PrOSPeCT is Australia’s largest precision oncology initiative. Delivered by Omico and a national network of healthcare, research and industry partners, it provides eligible Australians with access to molecular profiling and matching to biomarker-led clinical trials and therapies (at no cost to the patient), while generating clinical, genomic, treatment and outcomes data to advance research, improve cancer care and inform future health policy.

Fortrea Contacts:
Galen Wilson (Media) – 703-298-0802, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
Tracy Krumme (Investors) – 984-385-6707, Tracy.Krumme@fortrea.com

Omico Contact:
Kym Bramich (Communications) – +61 414 795 087, k.bramich@omico.org.au